AtriCure to Announce Second Quarter 2022 Financial Results
July 12 2022 - 8:00AM
Business Wire
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical
treatments and therapies for atrial fibrillation (Afib), left
atrial appendage (LAA) management, and post-operative pain
management, today announced that it will release its second quarter
2022 financial results on Tuesday, August 2, 2022.
AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on
Tuesday, August 2, 2022, to discuss its second quarter 2022
financial results. To access the webcast, please visit the
Investors page of AtriCure’s corporate website at
https://ir.atricure.com/events-and-presentations/events.
Participants are encouraged to register more than 15 minutes before
the webcast start time. A replay of the webcast will be available
for 90 days following the presentation.
About AtriCure
AtriCure, Inc. provides innovative technologies for the
treatment of Afib and related conditions. Afib affects more than 33
million people worldwide. Electrophysiologists and cardiothoracic
surgeons around the globe use AtriCure technologies for the
treatment of Afib and reduction of Afib related complications.
AtriCure’s Isolator® Synergy™ Ablation System is the first medical
device to receive FDA approval for the treatment of persistent
Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System
products are the most widely sold LAA management devices worldwide.
AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure
that provides a lasting solution for long-standing persistent Afib
patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for
temporary ablation of peripheral nerves to block pain, providing
pain relief in cardiac and thoracic procedures. For more
information, visit AtriCure.com or follow us on Twitter
@AtriCure.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220712005125/en/
Angie Wirick AtriCure, Inc. Chief Financial Officer (513)
755-5334 awirick@atricure.com
Lynn Lewis Gilmartin Group Investor Relations (415) 937-5402
lynn@gilmartinir.com
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Apr 2024 to May 2024
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From May 2023 to May 2024